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Background: Family history (FH) is considered an important factor to detect individuals at increased risk
developing type 2 diabetes (T2D). Moreover, FH information could be used to personalise risk messages, which are
assumed to increase risk-reducing behaviours. In this study, we aimed to explore Dutch health care professionals’
attitudes regarding current or future uptake of a more extensive use of FH information and the family system in
diabetes prevention.
Methods: Semi-structured interviews were conducted with nineteen health care professionals from six general
practices and four outpatient diabetes clinics. The use of FH information in opportunistic screening for T2D was
explored, as well as the usability of a direct versus patient-mediated targeting strategy to reach persons with a FH
of T2D. Three researchers analysed the interview transcripts separately.
Results: Dutch health care professionals considered FH an important risk factor in opportunistic screening for T2D.
However, none of them used FH to promote risk-reducing behaviours. Directly targeting and educating patients
known to have a FH of T2D was desirable for most primary care professionals, but not considered feasible. Findings
indicated that FH information was not systematically gathered in primary care settings and electronic medical
records were not equipped to retrieve persons with T2D running in their family. The idea of asking patients to pass
on risk and preventive information was new to all interviewees, but was considered an acceptable strategy to reach
persons with a FH of diabetes. Nevertheless, there were concerns about the accuracy of the messages delivered by
the patients to their relatives. Practical barriers with regard to time, expertise, and financial reimbursement were
also mentioned.
Conclusions: There is great interest among healthcare professionals in primary as well as secondary care about the
use of FH to prevent T2D, but there are significant barriers against such use. The removal of these barriers would
depend on evidence showing the cost-effectiveness of FH-based strategies designed to prevent T2D.
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Table 1 Distribution of interviewees according to gender
and years of clinical experience#
Primary care Secondary care
GPs PNs DSs DNs
Included practices/outpatient clinics 6 4
Number of interviewees§ 5 6 5 3
Gender
Male 3 - 4 1
Female 2 6 1 2
Clinical experience
0-10 years - 6 2 2
11-20 years 2 - 2 -
21-30 years 1 - 1 1
> 31 years 2 - - -
Notes: GPs=General practitioners, PNs=Practice Nurses, DSs=Diabetes
Specialists, DNs=Diabetes Nurses.
# All interviewees were from Dutch origin.
§ In one general practice, the GP and PN were interviewed at the same time.
In another general practice, two PNs were interviewed at the same time. One
PN worked in two general practices that were both included in the study.
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Type 2 diabetes (T2D) is a serious chronic disease caus-
ing considerable burden on patients as well as health
care systems [1]. The rapidly increasing prevalence of
T2D warrants major efforts to explore effective tools
and strategies to detect, inform and motivate individuals
at high risk to engage in preventive actions [2].
T2D is best described as a multi factorial disease, which
means disease onset is triggered by the interaction of mul-
tiple genes and environmental factors [3]. Research has
convincingly demonstrated that T2D is highly prevalent in
some families and a positive family history predicts the de-
velopment of T2D, even after adjustment for common risk
factors [4-6]. Consequently, a family history (FH) of T2D is
seen as a valuable tool in preventive activities [7]. FH infor-
mation can help to detect persons at increased risk devel-
oping T2D: the chance of developing diabetes is two-to
-five times higher for people with a FH of the disease
[6,8,9]. Moreover, evidence suggests that preventive mes-
sages tailored to a person’s FH can increase risk awareness
and risk-reducing behaviours [10-12]. Yet, interventions
using FH information to promote a healthy lifestyle seem
to be scarce [13].
In most Western countries, the use of opportunistic
screening targeting patients at risk for T2D is encouraged
[14]. In combination with other risk factors, FH is recog-
nized as an important element in the risk stratification pro-
cedure. Directly targeting and educating people known to
have T2D running in their family, however, is not current
in clinical practice [11,12,15]. Yet, there is an increasing
need for structured preventive activities linked to primary
care [16]. A targeting approach that might be worthwhile
to explore in this context is patient-mediated cascading, as
is used in screening for familial hypercholesterolemia [17].
This means that relatives are reached via the index patient,
who informs them about increased familial susceptibility to
a disease and the preventive options. Research already has
indicated that the majority of patients with T2D seems
willing to disseminate risk and preventive information in
their family [18,19]. Adult offspring generally appears re-
ceptive to be informed about reducing their diabetes risk
via the family system [20].
In this study, semi-structured interviews with Dutch
health care professionals were conducted to investigate
opinions, attitudes and practices with regard to the
current and future use of FH in preventive consultations.
Ideas regarding two potential strategies to reach persons
with T2D running in their family were explored: 1) dir-
ectly targeting patients known to have a FH of T2D and
2) a patient-mediated approach, asking patients with
T2D to pass on risk information to first-degree and
second-degree relatives. After all, increased T2D risk is
present in first-degree as well as second-degree relatives
[8,21]. Moreover, although preventive activities usually arecarried out in primary health care, we considered opinions
of secondary care professionals also of relevance in this
study. Patients receiving diabetes treatment in secondary
care visit outpatient clinics regularly, which might provide
opportunities to discuss the familial character of the dis-
ease. Findings may provide insight in the uptake of FH as a
tool in T2D prevention and the conditions that are needed
to apply family-based strategies in routine care.
Methods
Design and participants
Between February and April 2010, two researchers (SvE
and WH) conducted nineteen semi-structured inter-
views with Dutch health care professionals. A purposive
sampling strategy was used, aiming to achieve maximum
variation in the characteristics of the included affiliations
and professionals [22]. General practices were recruited
via the regional network of the Academic General Prac-
tice of the VU University Medical Center. Six practices
in three cities in the urban area of Amsterdam were will-
ing to participate. Interviews were conducted with five
general practitioners (GPs) and six practice nurses
(PNs). The term ‘general practice’ is commonly used in
the Dutch health care system and is considered syn-
onymous to ‘family medicine’ and ‘family practice’.
Diabetes specialists (DSs) and diabetes nurses (DNs) in
secondary care were approached via contacts of the au-
thors in four outpatient diabetes clinics in Amsterdam.
Interviews were conducted with five DSs and three DNs.
The study sample included professionals of both sexes
and varying years of clinical experience (see Table 1). All
interviewees were of Dutch origin. Affiliations varied in
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Table 2). All interviewees gave informed consent prior
to the interview. The VU University Medical Center Eth-
ics Committee approved the study.
Interview guide
The interviews were semi-structured and based on a
topic guide (see below) that was pilot tested in two
interviews. In the first part of the interview, inter-
viewees were asked to describe current practice with
regard to the use of (opportunistic) screening for
T2D, assessment and registration of FH and struc-
tured education targeting patients at risk developing
T2D. Individual opinions with regard to bringing up
FH as a topic of conversation in preventive consulta-
tions were explored. Next, two potential strategies to
reach relatives of T2D patients were discussed: 1)
directly targeting patients known to have a FH of
diabetes and 2) indirectly targeting, i.e. asking pa-
tients to pass on information to first-degree and
second-degree relatives. Considerable flexibility dur-
ing the interviews allowed interviewees to discuss
and elaborate on issues that were most important to
them. Each interview lasted about half an hour and
took place in the participants’ work environment.
The interview guide included the following topics
(* indicated topics are only discussed with primary
care professionals).
Introducing the interview
“With the increasing incidence, primary prevention of
type 2 diabetes is of key importance. Clinical and
public health efforts are generated to assist in reducing
the burden of diabetes in the population. In thisTable 2 Distribution of the general practices (N=6) and
outpatient clinics (N=4) according to key characteristics
of their patients‡
Primary care Secondary care
Social economic status
Low 3 3
Low and average 1 -
Average 1 -
Average and high 1 1
Ethnic backgrounds
Majority of Dutch origin 4 1
Majority of non-Dutch origin 2 3
Age distribution
Normal distribution 4 4
> 65 years overrepresented 2 -
‡Professionals were asked to define their patient population according to
socioeconomic status (SES), ethnic backgrounds and age distribution.interview, we aim to explore the current and future
uptake of proactive patient education about familial
susceptibility to type 2 diabetes”.
Mapping current practice
 Are patients at risk developing type 2 diabetes
systematically screened in this general practice?*
○ In case of opportunistic screening: which risk
factors are assessed?
○ Can you describe the practical implications of the
screening process?
 Is family history of type 2 diabetes systematically
assessed (if yes, how registered)?
 Is education about risk factors and preventive
options systematically offered when patients are at
risk developing type 2 diabetes (but not yet
diagnosed)?*
○Which risk factors are emphasized?
○ To which extent is family history discussed?
Exploring perceptions and attitudes
 What is your opinion about using family history as a
topic of conversation to promote health protective
behaviour?*
○ Do you use family history to personalize
preventive messages?
○ Do you think it will be effective to promote
healthy behaviour?
 What is your opinion about proactively targeting
patients with a family history of type 2 diabetes to
educate them about preventive options?*
○ Do you think it is effective (e.g., with regard to
patient empowerment/responsibility/ privacy)?
○ Do you think it is feasible?
 What is your opinion about asking patients to
deliver diabetes risk and preventive messages in
their family (first-degree as well as second-degree
relatives)? Elaborate on:
○ Patients’ willingness
○ Potential effect on relatives
○ Feasibility
○ Familial and/or cultural aspects
 What would be needed to implement family-based
strategies in diabetes prevention?
 Are you familiar with the information that is
provided by mass media campaigns and websites
aiming to raise public awareness about familial
susceptibility to type 2 diabetes?
○ Do you use this information and/or refer patients
to these websites?
Data analysis
All interviews were digitally recorded, transcribed verba-
tim (WC) and checked for errors (SvE and WH).
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used for data coding and retrieval. The transcripts were
analysed using thematic content-analytical techniques.
Main codes were established for the core questions in
the interview guide; sub-codes were inductively formu-
lated to identify emerging sub-themes. Two investigators
(SvE and WC, or WH and WC) independently coded
each transcript. Ambiguities in the final code-lists were
discussed until consensus was reached. Subsequently,
(sub-)codes were grouped in thematic matrices and simi-
larities, variations and patterns amongst the professional
groups were summarized. Main findings were discussed
with all members of the study group. The quotations
that follow were chosen to reflect a range of both con-
sensual and dissenting views. Identification numbers are
placed between square brackets and include participants’
professional background (GP, NP, DS or DN) and the
number that was assigned to the practice/clinic.
Results
Mapping current practice
All included GPs work in accordance with the Dutch
guideline for diabetes treatment, which include oppor-
tunistic screening for T2D [23]. One GP participated in a
trial to implement the screening protocol for cardio-
metabolic prevention, targeting all patients >55 years old
[16,24]. All interviewees perceive FH (specifically in first-
degree relatives) as important factor in the risk stratifica-
tion procedure. However, according to the interviewees
in primary care, the assessment of FH information is not
standardized; a person’s FH of diabetes is inquired the
moment it is thought to be of relevance. Professionals
vary in asking about second-degree relatives with T2D.
In diabetes outpatient clinics, FH is systematically
assessed during the first consultation. Both in primary
and secondary care, FH information is registered in elec-
tronic medical records (EMRs), but not with a retrievable
code. When patients are diagnosed with (pre)diabetes,
they are regularly monitored and receive education about
T2D risk factors and lifestyle modifications to prevent
diabetes complications (secondary prevention).
Using family history information in preventive actions
Data revealed that the extent to which the multifactorial
aetiology of T2D is explained varied between profes-
sionals: ‘It depends on the patient, whether (s)he is inter-
ested. But I try to explain that some people are more at
risk than others.’ [GP4]. Some GPs and PNs do not
emphasize the role of FH as a risk factor, as it is not a
factor that can be changed: ‘We think monitoring weight
and blood glucose levels in this population is most effect-
ive. We don’t emphasize family history.’ [GP3] ‘Under-
standing the balance between food consumption and
energy expenditure, that’s what counts.’ [GP5].None of the interviewees used FH information to pro-
mote health-protective behaviour. The clarification of
what FH could mean to a person by professionals seems
to be minimal. Professionals could not bring up absolute
or relative risk estimates of developing T2D in persons
with a FH. Nevertheless, they agreed that personal per-
ceptions about diabetes running in the family could be
discussed more thoroughly and knowledge about familial
susceptibility to diabetes could be improved: ‘There is a
lot of ignorance. [. . .] People don’t recognize diabetes
symptoms, despite the –sometimes high- diabetes preva-
lence in their family.’ [GP4]. The idea of using FH infor-
mation to motivate risk-reducing behaviour was new to
all interviewees, but it was acknowledged that for some
relatives, personalized risk messages could be a cue to
action: ‘I think, targeting family members could be effect-
ive. However, I think you should reach them in a neutral
and thoughtful manner. People don’t want you to inter-
fere with their personal life too much.’ [GP2].
All primary care professionals reported to be inter-
ested in new strategies and tools to inform people about
the importance of a healthy lifestyle. Interestingly, with
exception of one PN, none of the interviewees had paid
attention to or used the information provided by re-
nowned Dutch health organizations. Between 2009 and
2013, diverse mass medial campaigns and an informative
website were launched [25], providing a diabetes risk test
that generates personalized preventive information [26].
Directly targeting patients at familial risk developing type
2 diabetes
Most GPs and PNs indicated that directly targeting and
educating populations at risk, including persons with a
FH, would be desirable and worthwhile: ‘We plan to set
up more preventive activities targeting patients with an
extensive family history of cardiovascular disease and
type 2 diabetes.’ [GP4]. However, they foresee practical
problems; lack of time, finance and organizational bar-
riers were reported: ‘What we need is a continuing ap-
proach. Our PNs are trained to provide patient
education and motivate patients in the process of behav-
iour change. [. . .] We could organize and facilitate a
structured programme, on condition that financial re-
sources are available.’ [GP2]. Most importantly, however,
directly targeting patients with a FH is not possible be-
cause EMRs are not equipped to retrieve persons with a
FH: ‘The most important barrier is to identify and reach
patients with an extensive family history.’ [PN6b].
Asking patients to pass on risk and preventive messages
in their family
The idea of asking patients to inform relatives about fa-
milial susceptibility to T2D appeared to be new to all in-
terviewees. During the interviews, the professionals
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proach to reach relatives at risk: ‘When you think about
prevention, you have to reach as much people as possible.
I do not disapprove this kind of targeting approach.’
[PN4&5]. Interviewees referred to patients who bring up
inheritance and concern about the future health of their
relatives themselves. They commended on the possibility
of contacting otherwise unreachable healthy individuals
and thought that a specific group of patients seems will-
ing to disseminate information in their family: ‘Patients
who adequately handle their disease will be motivated to
participate. Other patients are into denial and/or strug-
gling with their disease. You can’t ask these patients to
deliver diabetes risk messages in their family.’ [PN6a].
However, for some GPs it was difficult to think about
targeting a population that does not necessarily include
their own patients: ‘I think it is difficult to manage,
sometimes I ask about relatives, but most relatives are
not registered as a patient in our practice.’ [GP1]. More-
over, besides a lack of time during their consultations,
they indicated that they would need expertise and skills
to guide and educate patients who are willing to serve as
a messenger in their family.
Family-based diabetes prevention in secondary care
Most interviewees in secondary care do not think they
should have an active role in the primary prevention of
T2D, however, they are open to the idea of informing
patients and their relatives about familial susceptibility
to T2D: ‘Indeed, we talk about family history. When pa-
tients or relatives ask about it, I inform them about the
importance of a healthy lifestyle and advice relatives to
consult their GP for a yearly check-up.’ [DS2]. One DS
realized that in other situations, they have a more active
role with regard to prevention in families at high risk de-
veloping a disease: ‘We always inform patients about fa-
milial susceptibility in case of monogenetic disorders. The
problem with T2D is its multifactorial aetiology; the mes-
sage is not clear and more difficult to explain.’ [DS1].
One DN thinks every health care professional should
be concerned about a population at risk, but emphasized
that there are little opportunities to act upon that in sec-
ondary care. Other professionals were interested in the
idea of initiating conversations in families at risk: ‘I think
patients can tell from their own experience what it’s like
to have the disease [. . .] Most of my patients have adult
offspring. That would be a good target population.’
[DS4]. They emphasized the importance of repeating
health-protective messages: ‘Repetition is important in
health education. [. . .] It seems a good idea that people
hear the same message over and over again: from public
health communications, in general practice, from dieti-
cians and from us.’ [DS1]. Another professional, how-
ever, stated that a patient-mediated targeting approach isnot appropriate in secondary care: ‘Some patients in sec-
ondary care are quite sick. You can’t ask them to inform
their relatives.’ [DN2].
Perceived barriers regarding a patient-mediated targeting
approach
Notwithstanding the interest and enthusiasm of most in-
terviewees, some questioned the feasibility and benefits
of a patient-mediated approach in diabetes prevention:
‘Patients don’t want to deliver bad news and relatives
don’t want to receive such messages.’ [DS3a]. They
doubted whether patients would be able to pass on ac-
curate messages and whether relatives will be alarmed:
‘Will the messages be delivered? To be honest, considering
our patient population, I suppose a substantial amount
will not.’ [PN4&5]. As T2D is a lifestyle related disease,
many patients would not fulfil a role model with regard
to health behaviour: ‘I think the most important factor is
how patients experience and cope with their disease and
how visible it is for relatives.’ [PN1]. Interestingly, nurses
(PNs and DNs) seemed to be more hesitative than med-
ical professionals (GPs and DSs).
Different professionals mentioned strong family bond-
ing in ethnic minority families as a potential advanta-
geous factor: ‘Family tights seems to be stronger in
immigrant families.’ [DS3]. Conversely, other profes-
sionals emphasize cultural and linguistic barriers. Some
GPs and PNs do not expect benefits from illuminating
the familial character of T2D in ethnic minority groups
because of differences in perceived controllability with
regard to health and illness, causal attributions, gener-
ational conflicts and low literacy: ‘The illness burden of
first generation migrants might not impress the younger
generations. These youngsters do not identify with their
parents as far as health-related issues are concerned.’
[GP5]. Asking non-Dutch patients to pass on informa-
tion seems not feasible according to these professionals:
‘It’s the other way around. Those children are used to
translate during consultations and provide their parents
with health information. They won’t listen to their par-
ents and will search for information themselves when
they need it.’ [GP4].
Moreover, the younger generation in general would
not be admissible to risk messages via the family system:
‘I question whether it’s effective. Younger offspring is not
concerned with future health risks.’ [GP1] ‘Do children
listen to their parents? [. . .] I think a person will be inter-
ested the moment (s)he is confronted with the problem.’
[DS3a].
Discussion
Findings in this study indicated that Dutch health care
professionals seem to be interested in a more extensive
use of FH information, even though they were
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understanding of familial risk to promote and motivate
health-protective behaviour. However, the effectiveness of
illuminating FH was questioned, especially with regard to
patients of non-Dutch descent and younger generations.
Studies have indicated that targeted diabetes education ac-
tually does increase the recognition of diabetes risk,
screening possibilities, perceived personal control and the
need of healthy behaviour in persons with a FH of T2D
[10-12,27,28]. Moreover, relatives who were informed via
the family system perceived themselves at increased risk
developing diabetes [20,29]. Nevertheless, professionals are
right in stating that the effect of using FH in preventive
communications targeting specific populations remains
undetermined [10-12]. We only know that in families with
different ethnic backgrounds (e.g., South-Asian, Middle-
Eastern), family communication about T2D is not a taboo
and patients seem willing to pass on risk and preventive in-
formation in their family [18,30].
Generally, the study findings lend support for the
adoption of direct as well as indirect (patient-mediated)
strategies targeting persons with T2D running in their
family. Both methods seem effective in other disease
areas [17]. In Dutch primary care practice, a direct and
active invitation of the GP increased the screening up-
take of participants for a lifestyle intervention on T2D
risk reduction [16,31]. According to some interviewees,
however, structurally targeting individuals with a FH of
T2D was not considered feasible. Besides practical bar-
riers with regard to time, expertise and financial reim-
bursement, they indicated that FH is not systematically
registered and EMRs are not equipped to retrieve per-
sons with a FH of T2D. This problem was reported in
earlier research [15,32]. In the future, the development
of tools to collect standardized FH that are compatible
with EMRs may solve this obstacle [33]. Meanwhile, the
implementation of a proactive disease prevention protocol
linked to Dutch primary care may create opportunities to
initiate conversations about FH more systematically
[16,24]. A lifestyle intervention that uses FH to motivate
relatives of T2D patients to maintain good health is cur-
rently being evaluated [34].
The idea of asking patients to pass on risk information
was new to all interviewees, but was considered an ac-
ceptable strategy to reach persons with a FH. Neverthe-
less, quite a lot of professionals (especially nurses) were
sceptical about the potential benefits of such a strategy.
They doubted whether patients would be able to deliver
accurate messages in their family. Research already has
demonstrated that it would be advisable to provide pa-
tients with written information when they are asked to
deliver risk and preventive messages in their family.
Written information about familial hypercholesterolemia
reduced patients’ hesitation and appeared to be helpful inthe disclosure of family risk. In another study, informa-
tion packages served as a cue to action for relatives and
legitimated them to ask for a medical check-up [35].
A study in Japan has indicated that booklets with in-
formation about T2D risk and prevention, which were
handed over by patients, worked effectively on attitudes
and preventive behaviours in relatives. Yet, the reliability
of patients as information deliverers appeared to be lim-
ited [36]. This latter finding underlines the doubts that
some interviewees expressed in our study. Professionals’
concern that patients may fulfil a negative role model in
their family was also indicated as a barrier in the disclosure
of family risk by patients themselves [19]. Nevertheless, pa-
tients diagnosed with familial hypercholesterolemia seem
to prefer a patient-mediated approach more than a direct
targeting approach, as they consider it less threatening for
relatives [17].
Limitations
In this study, data were collected from a sample of dia-
betes care professionals in the Netherlands, representing
most important disciplines in primary and secondary dia-
betes care. Interviews were conducted in an urbanised
area, though there are no indications that this may limit
the study’s generalizability to all diabetes professionals in
the Netherlands. The Dutch health care system, however,
might restrict generalizability to an international context.
Moreover, the study sample could have had an impact on
the results. Socio-demographic characteristics of the in-
terviewees (for instance their age and national origin)
could influence their view that non-Dutch and younger
patients were least likely to respond to illuminating fam-
ily history as a risk factor.
Finally, it should be noticed that the idea of asking pa-
tients to inform relatives about familial susceptibility to
T2D was new to all interviewees. It would be interesting
to explore opinions of professionals who have consid-
ered these issues more thoroughly, as (in)directly
targeting relatives of index patients may raise ethical
questions [17]. In addition, more insight is needed in
cultural aspects regarding the disclosure of family risk,
the effect of low health literacy and negative modelling
in families at risk when utilizing family-based strategies
in diabetes prevention.
Conclusions
The results of this study suggest that health care profes-
sionals in primary, as well as secondary care are open to
the idea of using FH in preventive activities. In Dutch
primary care, the future implementation of a protocol
for proactive prevention of non-communicable diseases
[16,24] might provide opportunities to systematically
discuss patients’ interpretation of familial susceptibility
to a disease and potential effects on health-related
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information that is made available by national public
health initiatives to inform populations at risk develop-
ing T2D, including persons with a FH of the disease
[37]. More importantly, however, for professionals to adopt
family-based strategies in the prevention of T2D, convin-
cing evidence is needed regarding the cost-effectiveness.
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